Home » RECOJET TEST MARKETED IN INDIA
RECOJET TEST MARKETED IN INDIA
Antares Pharma has announced that initial sales of recombinant human insulin along with Antares Pharma's needle-free injection device, the Medi-Jector VISION, have begun in India under the trade name Recojet. Recojet combines Antares Pharma's VISION needle-free injection technology with recombinant human insulin supplied by Singapore-based SciGen, under the local brand name of Recosulin, and is distributed by Mumbai, India-based Shreya Life Sciences.
PharmaLive
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
14May
-
23May
-
30May
-
20Jun
-
21Oct